The most recurrent monogenic disorders that overlap with the phenotype of Rett syndrome
Author
dc.contributor.author
Vidal, S.
Author
dc.contributor.author
Brandi, N.
Author
dc.contributor.author
Pacheco, P.
Author
dc.contributor.author
Maynou, J.
Author
dc.contributor.author
Fernandez, G.
Author
dc.contributor.author
Xiol, C.
Author
dc.contributor.author
Pascual-Alonso, A.
Author
dc.contributor.author
Pineda, M.
Author
dc.contributor.author
O'Callaghan C., Maria del Mar
Author
dc.contributor.author
Garcia-Cazorla, Àngels
Author
dc.contributor.author
Serrano Munuera, Maria
Author
dc.contributor.author
García, Silvia Cuso
Author
dc.contributor.author
Troncoso, Monica
Author
dc.contributor.author
Fariña, Guillermo
Author
dc.contributor.author
García Peñas, Ju
Admission date
dc.date.accessioned
2019-10-30T15:40:06Z
Available date
dc.date.available
2019-10-30T15:40:06Z
Publication date
dc.date.issued
2019
Cita de ítem
dc.identifier.citation
European Journal of Paediatric Neurology, Volumen 23, Issue 4, 2019, Pages 609-620
Identifier
dc.identifier.issn
15322130
Identifier
dc.identifier.issn
10903798
Identifier
dc.identifier.other
10.1016/j.ejpn.2019.04.006
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/172535
Abstract
dc.description.abstract
Rett syndrome (RTT) is an early-onset neurodevelopmental disorder that is caused by mutations in the MECP2 gene; however, defects in other genes (CDKL5 and FOXG1) can lead to presentations that resemble classic RTT, although they are not completely identical. Here, we attempted to identify other monogenic disorders that share features of RTT. A total of 437 patients with a clinical diagnosis of RTT-like were studied; in 242 patients, a custom panel with 17 genes related to an RTT-like phenotype was run via a HaloPlex-Target-Enrichment-System. In the remaining 195 patients, a commercial TruSight-One-Sequencing-Panel was analysed. A total of 40 patients with clinical features of RTT had variants which affect gene function in six genes associated with other monogenic disorders. Twelve patients had variants in STXBP1, nine in TCF4, six in SCN2A, five in KCNQ2, four in MEF2C and four in SYNGAP1. Genetic studies using next generation sequencing (NGS) allowed us to study a larger number of genes associated with RTT-like simultaneously, providing a genetic diagnosis for a wider group of patients. These new findings provide the clinician with more information and clues that could help in the prevention of future symptoms or in pharmacologic therapy.